How To Use CPT Code 83014

CPT 83014 describes the administration of drugs for testing the presence of Helicobacter pylori bacteria. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 83014?

CPT 83014 can be used to describe the administration of drugs for testing the presence of Helicobacter pylori bacteria. This code is used when a lab analyst administers a drug to a patient that consists of urea chemically attached to an isotope, typically carbon 13. The presence of H. pylori is determined by measuring the amount of radiolabeled carbon dioxide in the patient’s breath.

2. Official Description

The official description of CPT code 83014 is: ‘Helicobacter pylori; drug administration.’

3. Procedure

1. The lab analyst begins the procedure by collecting a baseline breath sample from the patient.
2. A drug consisting of urea chemically attached to an isotope, typically carbon 13, is administered to the patient.
3. The lab analyst collects breath samples from the patient at regular intervals to measure the presence of radiolabeled carbon dioxide, indicating the presence of H. pylori.
4. The breath samples are analyzed separately using a breath test analysis code, such as CPT code 83013.

4. Qualifying circumstances

CPT 83014 is used when a patient requires testing for the presence of Helicobacter pylori bacteria. This test is most commonly performed on patients with suspected stomach or duodenal ulcers. The patient must be prepped for the test, and the lab analyst must administer the drug and collect breath samples for analysis.

5. When to use CPT code 83014

CPT code 83014 should be used when a lab analyst administers drugs for testing the presence of Helicobacter pylori bacteria. It is important to note that this code only covers the drug administration portion of the test. For the breath test analysis, a separate code, such as CPT code 83013, should be used.

6. Documentation requirements

To support a claim for CPT code 83014, the following documentation is required:

• Confirmation of the patient’s need for testing for Helicobacter pylori bacteria
• Details of the drug administered, including the type of urea and isotope used
• Date and time of drug administration
• Baseline breath sample measurement
• Collection of breath samples at regular intervals
• Signature of the lab analyst administering the drug

7. Billing guidelines

When billing for CPT code 83014, ensure that the drug administration is performed by a qualified lab analyst. It is important to use the appropriate code for the breath test analysis, such as CPT code 83013, to report the analysis portion of the test. CPT code 83014 should not be reported with other codes for H. pylori testing, such as stool, liquid scintillation counter, or immunoassay codes.

8. Historical information

CPT code 83014 was added to the Current Procedural Terminology system on January 1, 1999. There have been historical changes to the code, including updates in 2001 and 2005 to specify the drug administration and sample collection aspects of the test.

9. Examples

1. A lab analyst administers a drug for testing the presence of Helicobacter pylori bacteria in a patient with suspected stomach ulcers.
2. A patient undergoes drug administration for H. pylori testing as part of a diagnostic workup for gastrointestinal symptoms.
3. A lab analyst collects breath samples from a patient at regular intervals after administering a drug for H. pylori testing.
4. A patient with a history of H. pylori infection undergoes drug administration for monitoring the effectiveness of treatment.
5. A lab analyst administers a drug for H. pylori testing in a patient with a family history of stomach cancer.
6. A patient with recurring stomach pain undergoes drug administration for H. pylori testing to rule out an underlying infection.
7. A lab analyst collects breath samples from a patient after administering a drug for H. pylori testing as part of a research study.
8. A patient with a positive family history of H. pylori infection undergoes drug administration for screening purposes.
9. A lab analyst administers a drug for H. pylori testing in a patient with unexplained weight loss and gastrointestinal symptoms.
10. A patient with a history of H. pylori infection undergoes drug administration for monitoring the eradication of the bacteria.